Bryant S G, Guernsey B G, Doutre W H, Mansbridge B, Fisher S
Drug Inf J. 1985;19(1):7-12. doi: 10.1177/009286158501900102.
As one facet of a larger investigation evaluating the various means by which patients receive information concerning their medications, a telephone-based drug information service was established for selected public use. The purpose was to detail the growth and utilization of the service, characterize the type and importance of the questions asked, and compare the potential utility with that of the USP-DI patient package insert (PPI) in responding to the public's drug information requests. Availability of the toll-free number for the Prescription Drug Information Service (PDIS) was controlled by offering it only to outpatients receiving selected medicines from the pharmacy of a large university-based medical center. The PDIS was operated by clinical pharmacists who participated in completing standardized operational data forms after each drug information call by the public. Of those calls received, 91.7% were not of a serious nature and most commonly dealt with side effects, drug interactions, and drug identification. Fifty percent of first-time calls occurred within two days of the subject's visit to the pharmacy and 23.4% of the total PDIS calls were repeat contacts. Interestingly, 34% of the patients' questions could not have been answered using the standard USP-DI PPI.
作为一项评估患者获取药物信息的各种方式的大型调查的一个方面，设立了一项供特定公众使用的基于电话的药物信息服务。目的是详细说明该服务的发展和使用情况，描述所提问题的类型和重要性，并将其在回应公众药物信息请求方面的潜在效用与美国药典药物信息（USP-DI）患者用药指南（PPI）进行比较。通过仅向从一家大型大学医学中心药房领取特定药物的门诊患者提供免费电话号码，来控制处方药信息服务（PDIS）的可用性。PDIS由临床药剂师运营，他们在每次接到公众的药物信息咨询电话后，会参与填写标准化的运营数据表格。在接到的咨询电话中，91.7%并非严重问题，最常见的是关于副作用、药物相互作用和药物识别。50%的首次咨询电话是在患者前往药房后的两天内打来的，PDIS总咨询电话的23.4%是重复联系。有趣的是，34%的患者问题无法通过标准的USP-DI PPI得到解答。
